Derfor bør omhyggelig overvågning af faktor IX plasma aktivitet udføres så vel som beregning af farmakokinetiske parametre som genfindingshalveringstiden som klinisk indikeret for at justere doserne passende.
Therefore, close monitoring of factor IX plasma activity should be performed, as well as calculation of pharmacokinetic parameters such as recovery and half-life, as clinically indicated, in order to adjust doses as appropriate.